James W. Huston

James W. Huston

Morrison & Foerster LLP

Contact
View Bio
RSS

Latest Posts › Patent Litigation

Share:

"Generic" Logic Helps Branded Drug Achieve Dismissal

A federal district court has held that design defect claims against a brand pharmaceutical manufacturer are preempted by federal law. Booker v. Johnson & Johnson, No. 3:12 oe 40000, 2014 WL 5113305 (N.D. Ohio Oct. 10,...more

11/7/2014  /  Generic Drugs , Johnson & Johnson , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Preemption , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide